Cargando…
Selective estrogen receptor modulators and deep venous thrombosis after an emergent operation in senior women
BACKGROUND: Selective estrogen receptor modulators (SERMs), clinically applied to osteoporosis, may have potential risk of deep venous thrombosis (DVT) and discontinuation of SERMs may be required before surgery. However, we cannot discontinue SERMs for a certain duration, when patients undergo an e...
Autores principales: | Kishida, Keiko, Furukawa, Masanobu, Nakashima, Masayuki, Kubota, Idumi, Hayashi, Yukio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10624775/ https://www.ncbi.nlm.nih.gov/pubmed/37921988 http://dx.doi.org/10.1186/s40981-023-00665-1 |
Ejemplares similares
-
Hormonal therapies and venous thrombosis: Estrogen matters!
por: Morimont, Laure, et al.
Publicado: (2023) -
The role of emergency venography in the diagnosis and management of deep venous thrombosis.
por: Clarke, J. C., et al.
Publicado: (1990) -
Azithromycin/estrogen/hydroxychloroquine: Cerebral venous thrombosis: 2 case reports
Publicado: (2020) -
Surgical Operative Time Increases the Risk of Deep Venous Thrombosis and Pulmonary Embolism in Robotic Prostatectomy
por: Abel, E. Jason, et al.
Publicado: (2014) -
Cut-off value of D-dimer for prediction of deep venous thrombosis before treatment in ovarian cancer
por: Kawaguchi, Ryuji, et al.
Publicado: (2012)